Delivery Order SPE2DR25D3301-SPE2DR26F21UC
- Not listed
- The Defense Logistics Agency awarded a $4,445.95 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT (orally disintegrating tablet) 4 mg tablets in quantities of 30, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with DLA. The contract specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.49 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. The contract is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,529.94 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 milligram tablets (30-count units). This non-competitive delivery order, issued on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a firm fixed-price transaction for pharmaceutical supply to federal medical procurement needs. The contractor is based in Conshohocken, Pennsylvania, and serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,774.90 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction for pharmaceutical supplies to support...
- The Defense Logistics Agency awarded a $3,616.41 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablet) 4 mg in quantities of 30 tablets. This firm fixed-price delivery order, awarded on November 26, 2025, represents a non-set-aside competitive award with an ultimate completion date of November 28, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) valued at $11,571.36 under a firm fixed-price contract. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement to support federal medical supply needs, with performance to occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,348.60 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on January 30, 2026, with an ultimate completion date of February 2, 2026, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. The contract will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,944.58 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). The contract is a firm fixed-price delivery order with no set-aside designation, reflecting open and competitive procurement. The award was made on January 26, 2026, with an ultimate completion date of January 27, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with...
- The Defense Logistics Agency awarded a delivery order valued at $3,691.68 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count) on January 13, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 14, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The company is a subsidiary of Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.02 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This contract, designated as a firm fixed price delivery order with no set-aside provisions, was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21UCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,260.40 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (Orally Disintegrating Tablet) 4 mg tablets in a quantity of 30 units. This non-competitive delivery order was issued on February 3, 2026, with an ultimate completion date of February 4, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed-price pricing, a standard approach for pharmaceutical procurement that provides cost certainty for government medical supply chains. This delivery order was executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031). This prime indefinite delivery vehicle serves as the comprehensive pharmaceutical support mechanism enabling the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and veteran healthcare programs globally. AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain reflects its established capability to fulfill essential medication requirements across multiple therapeutic domains for the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 2/2/26 |